A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain
- Author
- HENDERSON, D. C1 2 ; FAN, X1 2 ; EVINS, A. E1 2 ; GOFF, D. C1 2 ; COPELAND, P. M2 3 ; BORBA, C. P1 ; DALEY, T. B1 ; NGUYEN, D. D1 ; ZHANG, H4 ; HAYDEN, D4 ; FREUDENREICH, O1 2 ; CATHER, C1 2
[1] The Schizophrenia Program, Massachusetts General Hospital, United States
[2] The Schizophrenia Program, Massachusetts General Hospital; and Harvard Medical School, United States
[3] Department of Medicine, Massachusetts General Hospital, Boston, MA, United States
[4] Biostatistics Center, Massachusetts General Hospital, Boston, MA, United States - Source
Acta psychiatrica Scandinavica. 2007, Vol 115, Num 2, pp 101-105, 5 p ; ref : 15 ref
- CODEN
- APYSA9
- ISSN
- 0001-690X
- Scientific domain
- Psychology, psychopathology, psychiatry
- Publisher
- Blackwell, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- clozapine lipids schizophrenia sibutramine weight
- Keyword (fr)
- Anorexigène Antipsychotique atypique Clozapine Etude double insu Lipide Neuroleptique Placebo Prise poids Schizophrénie Sibutramine Dibenzodiazépine dérivé Antagoniste Catécholamine Chimiothérapie Inhibiteur recapture Neurotransmetteur Noradrénaline Psychose Psychotrope Récepteur dopaminergique D2 Sérotonine Traitement
- Keyword (en)
- Anorectic Atypical antipsychotic Clozapine Double blind study Lipids Neuroleptic Placebo Weight gain Schizophrenia Sibutramine Antagonist Catecholamine Chemotherapy Reuptake inhibitor Neurotransmitter Norepinephrine Psychosis Psychotropic D2 Dopamine receptor Serotonin Treatment
- Keyword (es)
- Anorexígeno Antipsicótico atípico Clozapina Estudio doble ciego Lípido Neuroléptico Placebo Ganancia peso Esquizofrenia Sibutramina Antagonista Catecolamina Quimioterapia Inhibidor recaptura Neurotransmisor Noradrenalina Psicosis Psicotropo Receptor dopaminérgico D2 Serotonina Tratamiento
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C06 Psychoses / 002B18C06A Schizophrenia
- Discipline
- Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
- Origin
- Inist-CNRS
- Database
- FRANCIS ; PASCAL
- INIST identifier
- 18492249
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1600-0447.2006.00855.x 
https://dx.doi.org/10.1111/j.1600-0447.2006.00855.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2006.00855.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica Scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. Scand\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"115\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"101\";s:8:\"\u0000*\u0000epage\";s:3:\"105\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HENDERSON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"FAN, X\";i:1;s:11:\"EVINS, A. E\";i:2;s:10:\"GOFF, D. C\";i:3;s:14:\"COPELAND, P. M\";i:4;s:11:\"BORBA, C. P\";i:5;s:11:\"DALEY, T. B\";i:6;s:12:\"NGUYEN, D. D\";i:7;s:8:\"ZHANG, H\";i:8;s:9:\"HAYDEN, D\";i:9;s:15:\"FREUDENREICH, O\";i:10;s:9:\"CATHER, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2006.00855.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica Scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. Scand\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"115\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"101\";s:8:\"\u0000*\u0000epage\";s:3:\"105\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HENDERSON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"FAN, X\";i:1;s:11:\"EVINS, A. E\";i:2;s:10:\"GOFF, D. C\";i:3;s:14:\"COPELAND, P. M\";i:4;s:11:\"BORBA, C. P\";i:5;s:11:\"DALEY, T. B\";i:6;s:12:\"NGUYEN, D. D\";i:7;s:8:\"ZHANG, H\";i:8;s:9:\"HAYDEN, D\";i:9;s:15:\"FREUDENREICH, O\";i:10;s:9:\"CATHER, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2006.00855.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2006.00855.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica Scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. Scand\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"115\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"101\";s:8:\"\u0000*\u0000epage\";s:3:\"105\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HENDERSON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"FAN, X\";i:1;s:11:\"EVINS, A. E\";i:2;s:10:\"GOFF, D. C\";i:3;s:14:\"COPELAND, P. M\";i:4;s:11:\"BORBA, C. P\";i:5;s:11:\"DALEY, T. B\";i:6;s:12:\"NGUYEN, D. D\";i:7;s:8:\"ZHANG, H\";i:8;s:9:\"HAYDEN, D\";i:9;s:15:\"FREUDENREICH, O\";i:10;s:9:\"CATHER, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2006.00855.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica Scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. Scand\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"115\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"101\";s:8:\"\u0000*\u0000epage\";s:3:\"105\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HENDERSON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"FAN, X\";i:1;s:11:\"EVINS, A. E\";i:2;s:10:\"GOFF, D. C\";i:3;s:14:\"COPELAND, P. M\";i:4;s:11:\"BORBA, C. P\";i:5;s:11:\"DALEY, T. B\";i:6;s:12:\"NGUYEN, D. D\";i:7;s:8:\"ZHANG, H\";i:8;s:9:\"HAYDEN, D\";i:9;s:15:\"FREUDENREICH, O\";i:10;s:9:\"CATHER, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1600-0447.2006.00855.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Acta psychiatrica Scandinavica\";s:9:\"\u0000*\u0000stitle\";s:21:\"Acta psychiatr. Scand\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"115\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"101\";s:8:\"\u0000*\u0000epage\";s:3:\"105\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0001-690X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"HENDERSON\";s:10:\"\u0000*\u0000aufirst\";s:4:\"D. C\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:6:\"FAN, X\";i:1;s:11:\"EVINS, A. E\";i:2;s:10:\"GOFF, D. C\";i:3;s:14:\"COPELAND, P. M\";i:4;s:11:\"BORBA, C. P\";i:5;s:11:\"DALEY, T. B\";i:6;s:12:\"NGUYEN, D. D\";i:7;s:8:\"ZHANG, H\";i:8;s:9:\"HAYDEN, D\";i:9;s:15:\"FREUDENREICH, O\";i:10;s:9:\"CATHER, C\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"APYSA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:92:\"A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:9:\"Blackwell\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
